Wysdom Radio™

This episode tackles the "Goldilocks dilemma" of TIPS: finding the stent diameter that stops a life-threatening variceal bleed without silently destroying a patient's cognition. Listen to the end to hear the expert commentary from Ziv Haskal from University of Virginia.
  • Metabolic Cost: A TIPS decompresses the portal system but shunts ammonia-rich blood past the liver's filter and into the brain, where it triggers the astrocyte swelling behind hepatic encephalopathy (HE).
  • 8mm vs. 10mm: The Huang meta-analysis found that 8mm stents delivered better one- and three-year survival and lower HE risk than 10mm stents, despite slightly more shunt dysfunction.
  • 6mm vs. 8mm: The Zhang RCT randomized 144 cirrhotic patients to 6mm or 8mm stents. The 6mm group had a higher 2-year rebleeding rate (35.2% vs. 24.1%) but far less overt HE (20.3% vs. 42.0%), with nearly identical survival (84.6% vs. 83.0%).
  • Population Question: The Gong meta-analysis backs this up across mostly Asian cohorts, showing 6–7mm stents roughly halve HE risk versus 8mm without hurting survival. But the data leans on smaller Asian liver volumes and may not translate directly to Western patients.
  • Guideline Shift: EASL now recommends small-diameter stents for patients at high risk of HE, reflecting a shift toward accepting a bit more rebleeding risk to protect the brain.
  • Caveats: The Zhang trial was single-center and open-label, and Gong's conclusions lean on retrospective data that can't fully settle the shunt-dysfunction debate the way Huang's harder data can.
Tune in to learn why the field is moving from "bigger is safer" to personalized stent sizing based on individual liver anatomy.


This podcast is generated using an AI model that has been trained in the context of endovascular surgery and interventional radiology in addition context of the article cited below. The content was reviewed and edited by multiple healthcare professionals in the field.

Zhang W, Zhang M, Xiao J, et al. Efficacy of 6-mm and 8-mm Transjugular Intrahepatic Portosystemic Shunt for Variceal Bleeding: A Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2026;24(1):161-171. doi:10.1016/j.cgh.2025.06.023
Gong J, Xia Z, Zhou Z, Chen L, Wang X, Zhou F. Effectiveness and prognosis of covered stents with different diameters in transjugular intrahepatic portosystemic shunt: a meta-analysis. Eur J Gastroenterol Hepatol. 2024;36(2):229-237. doi:10.1097/MEG.0000000000002696
Huang Z, Yao Q, Zhu J, He Y, Chen Y, Wu F, Hua T. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: A systematic review and meta-analysis. Diagn Interv Imaging. 2021;102(5):279-285. doi:10.1016/j.diii.2020.11.004

What is Wysdom Radio™?

We deliver short, focused episodes on the main concepts and procedures you actually need to know. It’s the perfect clinical companion for your drive to work or your daily workout. Come learn IR on the go!

Check us out at https://www.medicalwysdom.ai/